Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: a systematic review and meta-analysis

被引：0
|
作者：
Mustafa Ali
Aruna Kumari Hira
Haris Jawaid
Faiza Zakaria
Zehra Somjee
机构：
[1] Dow University of Health Sciences,Dow Medical College
[2] Dow University of Health Sciences,Obstetrics & Gynaecology Unit I
来源：
Middle East Fertility Society Journal | / 26卷
关键词：
Elagolix; Uterine leiomyoma; Heavy menstrual bleeding; Meta-analysis; Add-back therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: a systematic review and meta-analysis
    Ali, Mustafa
    Hira, Aruna Kumari
    Jawaid, Haris
    Zakaria, Faiza
    Somjee, Zehra
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2021, 26 (01)
  • [2] A systematic review and meta-analysis comparing the use of elagolix therapy alone or in combination with add-back therapy to treat women with uterine fibroid associated heavy menstrual bleeding
    Wang, Xianying
    Li, Jingxin
    Liu, Yang
    Zheng, Yingying
    Wang, Xiaoli
    Liu, Guoqiang
    GLAND SURGERY, 2025, 14 (01) : 60 - 73
  • [3] Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids
    Al-Hendy, Ayman
    Bradley, Linda
    Owens, Charlotte D.
    Wang, Hui
    Barnhart, Kurt T.
    Feinberg, Eve
    Schlaff, William D.
    Puscheck, Elizabeth E.
    Wang, Alice
    Gillispie, Veronica
    Hurtado, Sandra
    Muneyyirci-Delale, Ozgul
    Archer, David F.
    Carr, Bruce R.
    Simon, James A.
    Stewart, Elizabeth A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (01)
  • [4] Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis
    Juliawati Muhammad
    Yusnita Yusof
    Imran Ahmad
    Mohd Noor Norhayati
    BMC Women's Health, 22
  • [5] Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis
    Muhammad, Juliawati
    Yusof, Yusnita
    Ahmad, Imran
    Norhayati, Mohd Noor
    BMC WOMENS HEALTH, 2022, 22 (01)
  • [6] Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis
    Debin Wu
    Min Hu
    Li Hong
    Shasha Hong
    Wenjuan Ding
    Jie Min
    Gui Fang
    Wenjun Guo
    Archives of Gynecology and Obstetrics, 2014, 290 : 513 - 523
  • [7] Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis
    Wu, Debin
    Hu, Min
    Hong, Li
    Hong, Shasha
    Ding, Wenjuan
    Min, Jie
    Fang, Gui
    Guo, Wenjun
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (03) : 513 - 523
  • [8] Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids
    Stewart, Elizabeth A.
    Archer, David F.
    Owens, Charlotte D.
    Barnhart, Kurt T.
    Bradley, Linda D.
    Feinberg, Eve C.
    Gillispie-Bell, Veronica
    Imudia, Anthony N.
    Liu, Ran
    Kim, Jin Hee
    Al-Hendy, Ayman
    JOURNAL OF WOMENS HEALTH, 2022, 31 (05) : 698 - 705
  • [9] The short- and mid-term efficacy and safety of elagolix in the management of pain associated with endometriosis: A systematic review and meta-analysis
    Zhang, Yue
    Wei, Wei
    Chang, En
    Leng, Yan-en
    Hou, Yi
    Wei, Xi
    Yue, Xin
    Zhong, Li
    Liu, Jin-feng
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2024, 53 (09)
  • [10] Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials
    Simon, James A.
    Stewart, Elizabeth A.
    Jewell, Susan
    Li, Moming
    Snabes, Michael C.
    F&S REPORTS, 2024, 5 (03): : 285 - 295
12345